CLINICAL ROLE -
FDA Plan to Combat Opioid Epidemic Highlights AJPB Week in Review
Top articles of the week from The American Journal of Pharmacy Benefits.
Read More
Gout Research to be Presented at American College of Rheumatology Meeting
Study finds high unmet need among patients with uncontrolled gout.
Precision Medicine May Span to Autoimmune Disorders
Biomarker identification may improve abatacept (Orencia) treatment for rheumatoid arthritis.
How Can Disruption be Beneficial to the Specialty Pharmacy Landscape?
Marc O’Connor, chief operating officer at Curant Health, discusses the benefits of disruption within the specialty landscape.
New Findings May Significantly Change Treatment for High Cholesterol
Elevated levels of high-density lipoprotein may not be beneficial for the heart.
Trastuzumab May Not Affect Reconstruction for Patients with HER-2 Breast Cancer
Trastuzumab monotherapy was not linked to surgical complications among patients with breast cancer undergoing reconstruction after a mastectomy.
Hospitals Plan to Sue Over Finalized 340B Changes
Hospital groups say that changes to the 340B program threaten access to treatment for Medicare beneficiaries.
Investigational Drug May Treat Rare Skin Condition
Current treatment options for dermatomyositis may be ineffective for some patients, according to a study presented at the American College of Rheumatology Annual Meeting.
Investigational Drug Shows Efficacy as Disease-Modifying Therapy for Knee Osteoarthritis
Medivir to present positive data at the annual meeting of the American College of Rheumatology.
Trending News Today: GOP Proposes Tax Reform Bill
Top news of the day from across the healthcare landscape.
Trending News Today: Trump Administration to Reverse Biosimilar Law
New CMS Rule Seeks to Lower Out-of-Pocket Costs for Medicare
Advocacy groups praise policy change towards reforming 340B and reducing drug costs for seniors.
Centers for Medicare and Medicaid Services Finalizes 340B Changes
Changes to 340B reimbursement will drastically lower out-of-pocket costs for Medicare beneficiaries.
Acid Reflux Drugs May Encourage Chronic Liver Disease
Proton pump inhibitors may lead to an imbalance of Enterococcus bacteria and increase the risk of liver injury.
Targeting Glucose Promising for Glioblastoma Therapy
Glucose is crucial for the growth of brain cancer cells.
Bacteria Involved in Slow Healing Wounds
Approximately 1 in 10 people will experience a poorly healing wound, which can lead to amputations in patients with diabetes.
Nerves May Sustain Prostate Cancer Progression
Norepinephrine may increase blood vessel growth in prostate cancer tumors.
Trending News Today: Open Enrollment 2018 Kicks Off
Trending News Today: Proposed Legislation Aims to Reduce Medical Waste
Pharmacy Times and Specialty Pharmacy Times Kick Off #APharmacistIs Social Media Campaign
Even beyond American Pharmacists Month, pharmacists deserve to be recognized for the important role they play in patient care.
Pharmacy Times and Specialty Pharmacy Times Launch #APharmacistIs Campaign
The #APharmacistIs campaign aims to increase awareness about the value of pharmacists.
Novartis Seeks New Indication for Gene Therapy Kymriah
Tisagenlecleucel (Kyrmiah) shows promise as a treatment for diffuse large B-cell lymphoma.
HIV Negatively Affects Children's Brains Despite Treatment
HIV-positive children administered antiretroviral therapy have changes in their white matter brain tissue.
FDA Highlights New Strategies to Combat the Opioid Epidemic
Novel methods to package, store, and dispose of opioids could fight the ongoing epidemic.
Therapeutic Arsenic Effective Against Glioblastoma
The addition of arsenic trioxide to standard therapy could triple glioblastoma survival.
Brain Glucose Levels Drop in Patients with Obesity, Diabetes
Low brain glucose levels may result in overeating among patients with obesity and type 2 diabetes.
Trending News Today: Generic Drug Pricing Lawsuit Expands
Trending News Today: Proton Pump Inhibitors May Increase Stomach Cancer Risk in Certain Patients
Mantle Cell Lymphoma Drug Gets FDA OK
The application for acalabrutinib in mantle cell lymphoma was previously granted priority review, breakthrough therapy, and orphan drug designations, according to the FDA.
PCSK9 Inhibitors Have High Prior Authorization Rejection Rate
Medicare-insured patients with heart disease had the greatest access to PCSK9 inhibitors.